Our previous targets additionally explored the Bcr-Abl oncogene and the transcription factor STAT5A in control of leukemic cell growth using similar non-viral techniques, so that the proposed delivery system could be a fruitful platform in RNAi-mediated leukemia therapy in general. This evidence concerns the gene STAT5A and leukemia.